ORMP
Oramed Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · US
$5.01
+1.62%Forward multiples
Based on analyst estimates
- P/E forward
- 6.26x
- P/E 2026E
- 1.11x
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- 1.18x
- PEG TTM
- —
- Price / book
- 0.66x
- Price / sales
- —
- Price / cash flow
- -37.43x
Enterprise value
- Enterprise value
- $158.5M
- EV / sales
- —
- EV / EBITDA
- 1.04x
- EV / EBIT
- -10.91x
- Market cap
- $208.4M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026